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Background. Neuregulin-1 (NRG1) is a putative schizophrenia susceptibility gene involved extensively in central nervous
system development as well as cancer invasion and metastasis. Using a B lymphoblast cell model, we previously demonstrated
impairment in NRG1a-mediated migration in cells derived from patients with schizophrenia as well as effects of risk alleles in
NRG1 and catechol-O-methyltransferase (COMT), a second gene implicated both in schizophrenia susceptibility and in cancer.
Methodology/Principal Findings. Here, we examine cell adhesion, an essential component process of cell motility, using an
integrin-mediated cell adhesion assay based on an interaction between ICAM-1 and the CD11a/CD18 integrin heterodimer
expressed on lymphoblasts. In our assay, NRG1a induces lymphoblasts to assume varying levels of adhesion characterized by
time-dependent fluctuations in the firmness of attachment. The maximum range of variation in adhesion over sixty minutes
correlates strongly with NRG1a-induced migration (r
2=0.61). NRG1a-induced adhesion variation is blocked by erbB2, PI3K, and
Akt inhibitors, but not by PLC, ROCK, MLCK, or MEK inhibitors, implicating the erbB2/PI3K/Akt1 signaling pathway in NRG1-
stimulated, integrin-mediated cell adhesion. In cell lines from 20 patients with schizophrenia and 20 normal controls, cells from
patients show a significant deficiency in the range of NRG1a-induced adhesion (p=0.0002). In contrast, the response of
patient-derived cells to phorbol myristate acetate is unimpaired. The COMT Val108/158Met genotype demonstrates a strong
trend towards predicting the range of the NRG1a-induced adhesion response with risk homozygotes having decreased
variation in cell adhesion even in normal subjects (p=0.063). Conclusion/Significance. Our findings suggest that a
mechanism of the NRG1 genetic association with schizophrenia may involve the molecular biology of cell adhesion.
Citation: Kanakry CG, Li Z, Nakai Y, Sei Y, Weinberger DR (2007) Neuregulin-1 Regulates Cell Adhesion via an ErbB2/Phosphoinositide-3 Kinase/Akt-
Dependent Pathway: Potential Implications for Schizophrenia and Cancer. PLoS ONE 2(12): e1369. doi:10.1371/journal.pone.0001369
INTRODUCTION
The predominant current view of the pathogenesis of schizophrenia
posits that it is a neurodevelopmental disorder related to genetic
factors that impact on brain development and plasticity.[1] Among
the steadily increasing number of putative schizophrenia suscepti-
bility genes is Neuregulin-1 (NRG1), which was first found to be
associated with increased risk for schizophrenia in an Icelandic
population[2] and subsequently confirmed in several studies of other
populations.[3] NRG1 exists in multiple isoforms, all of which
contain an epidermal growth factor (EGF)-like domain that can
signal through erbB2, erbB3, or erbB4 receptors.[4] Most NRG1
isoforms exist as transmembrane proteins that are believed to be
proteolytically cleaved, allowing the extracellular, EGF-like domain
to bind to erbB receptors.[5] NRG1 is involved in many key
neurodevelopmental functions, including neuronal migration, syn-
aptic modulation, and oligodendrocyte development. [4,6] Since
these functions and others regulated by NRG1 are at least
theoretically related to schizophrenia’s putative neurodevelopmental
origin, NRG1 is a biologically plausible schizophrenia susceptibility
gene. Nevertheless, the specific biologic mechanism of its genetic
association with schizophrenia and its role in disease pathogenesis
are unknown.
The use of B lymphoblasts asa cellmodel tostudy basicmolecular
mechanismsandgeneticassociationsofa numberofhumandiseases,
including neuropsychiatric disorders, is becoming increasingly
widespread.[7,8,9] The application of this model to explore cell
migration seems particularly appropriate given that neuronal and
immune cells share many common molecular and cellular features
important for cell motility.[10,11,12] Thus, molecular characteriza-
tion and genetic associations of cell motility in cells of hematopoietic
origin may provide insight into neuronal cellular processes. In recent
work using a B lymphoblast cell model, we showed that B
lymphoblasts express erbB2 and erbB3 receptors, and that NRG1a
signals through thesereceptorsvia thePI3K/Akt and PLC pathways
in order to promote chemotactic migration.[7] We also found that
genetic variation both in NRG1 and COMT previously associated
with schizophrenia predicted the migratory response of these cells to
NRG1, suggesting a potential cellular mechanism for the genetic
association to the disorder. In this study, we examine cell adhesion, a
fundamental component process involved in cell motility. To do so,
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PLoS ONE | www.plosone.org 1 December 2007 | Issue 12 | e1369we have developed an integrin-mediated cell adhesion assay in 96-
well plates based on an interaction between recombinant human
ICAM-1 and its CD11a/CD18 integrin heterodimer receptor
expressed on lymphoblasts.
Integrins are a class of cell surface receptors that play important
roles in a vast array of cellular and physiological processes, ranging
from embryonic development to immunity to tumor metasta-
sis.[13,14] Integrins form heterodimeric, transmembrane receptors
that consist of an a subunit non-covalently associated with a b
subunit. Integrins mediate signaling bidirectionally, helping to
integrate intracellular processes with the extracellular environ-
ment. Attachment of integrins to extracellular matrix proteins or
counterreceptors present on other cells activates so-called
‘‘outside-in’’ signaling that promotes a variety of cellular processes,
including the regulation of cell survival, proliferation, and
differentiation.[15] Meanwhile, chemokine and other chemical
stimulation of cells can modulate the adhesiveness of integrins,
promoting so-called ‘‘inside-out’’ signaling.[16,17,18,19]
Integrins also have been implicated as playing key functions in
mediating neuronal migration[20] and synapse formation and
maintenance. They play critical roles in a host of neurodevelop-
mental processes, including neuronal precursor cell adhesion, chain
migration, differentiation, and proliferation;[21,22] regulation of
neural-radial glial interactions and promotion of proper cortical
laminar organization through interactions with Reelin;[23] correct
migration of optic tectal neuroblasts into specific laminae;[24]
proper neural crest development;[25] neural growth cone filopodial
modulation;[26] oligodendrocyte survival;[27] and direction of
neuromuscular synaptogenesis and migration of Schwann cells to
the periphery.[28] Among their other roles in synapse biology are
promotion of synaptic maturation,[29] mediation of synaptic
plasticity,[30,31] and crucial involvement in LTP induction[32]
and stabilization[33,34] as well as spatial memory.[32]
Because NRG1 and integrins converge on various developmen-
tal processes linked to neuronal migration and to synapse biology
and given our previous findings related to NRG1-mediated cell
migration, we explored the effects of NRG1 activation of
lymphoblasts on integrin-mediated cell adhesion. We report that
NRG1a induces varying levels of cell adhesion characterized by
time-dependent fluctuations in the firmness of attachment as
measured with a novel adhesion assay. The maximum range of this
variation in adhesion over time (hereafter abbreviated as MRVA)
correlates highly with the effectiveness of NRG1a-induced cell
migration, indicating that the MRVA measure has biological
relevance, at least to these cells. NRG1a-induced MRVA is
dependent on erbB2/PI3K/Akt signaling. Furthermore, the
MRVA induced by NRG1a is significantly lower in B lymphoblasts
derived from patients with schizophrenia compared with those
derived from normal controls. Lastly, a single nucleotide
polymorphism within COMT, a gene implicated in susceptibility
both to schizophrenia and to metastatic cancer, demonstrates a
strong trend towards predicting the MRVA of a given cell line,
even in normal subjects. Overall, our studies show that NRG1
signaling activates adhesion machinery in a process that is impaired
in cells derived from patients with schizophrenia. If these findings
in immune cells are conserved in neuronal cell processes, they
would argue that a mechanism of the NRG1 genetic association
with schizophrenia involves the molecular biology of cell adhesion.
RESULTS
Lymphoblasts express integrins homogeneously
Lymphocytes predominantly express the CD11a/CD18 integrin
heterodimer (aL/b2, which is also known as leukocyte function-
associated antigen-1 or LFA-1).[35] We used flow cytometry to
assay baseline integrin expression and to compare expression
between cell lines derived from patients with schizophrenia versus
normal controls. All tested cell lines expressed CD11a (corrected
median fluorescence, 14.01860.968) and CD18 (14.33661.019),
except for one patient-derived cell line. This cell line was excluded
from all further testing and statistical comparisons. There was no
significant difference between cell lines derived from patients or
controls in the expression of either CD11a (patients (n=23),
13.47961.364; controls (n=35), 14.79061.303; p=0.5046) or
CD18 (patients (n=23), 14.21561.633; controls (n=35),
14.83261.291; p=0.7667). Correlation of CD11a with CD18
expression (linear regression (n=58), r=0.806; Fisher’s r to z,
p,0.0001) was consistent with the conclusion that CD11a and
CD18 principally were forming heterodimers with each other. Thus,
these data demonstrate that our lymphoblast cell lines express the
CD11a/CD18 integrins and that differential baseline expression of
these integrins is not a major factor in differences in migration[7] or
adhesion (see below) of patient-derived lymphoblasts.
NRG1a induces temporally varying cell adhesion
Initial experiments with our adhesion assay suggested that
adhesion had a time dependency. So, time course experiments
were performed in which lymphoblasts were exposed to NRG1a
orphorbolmyristateacetate (PMA)inICAM-coatedplatesforeither
15, 30, 45, or 60 minutes, and then the plates were washed to
remove cells that were not firmly adherent. PMA was used as a
positive control as it promotes cell attachment by directly activating
PKC. For each cell line, cells were subjected for the same time
exposure to the ICAM-coated plates in the absence of NRG1a or
PMA. Variation in the raw NRG1 attachment data (Figure S1) and
in the NRG/vehicle ratio over time (Figure 1, Figure S1, Figure S2,
and Figure S3) indicated that NRG1a-stimulated cells as a
population were fluctuating between states of relatively firmer and
weaker attachment compared with baseline control adhesion. In
order to quantify the observed variation in cell adhesion, we defined
the NRG1-induced maximum range of varying adhesion (MRVA)
as the maximum NRG/vehicle ratio minus the minimum NRG/
vehicle ratio of the four time points (Figure 1).
The maximum range of varying adhesion (MRVA)
appears characteristic of each cell line
To further address the reliability of these patterns, we performed
repeated adhesion assays on ten cell lines on two separate days.
These ten lineswereselected to provide a spectrum of MRVA values
inboth patient andcontrol celllines, including high, middle, and low
levelsof variation. Clear patterns of varying adhesion over time were
seen on both days, and though the actual pattern varied between
repeat runs in terms of the specific times that defined the range of
adhesion, the range of adhesion responses observed (i.e. the MRVA
measure) was highly reproducible (Spearman rank correlation
(n=10), rho=0.806, p=0.016) (Figure 1).
The MRVA of NRG1a-induced cell adhesion predicts
NRG1a-induced migration
The MRVA correlated positively and highly significantly with the
degree of chemotactic migration in response to NRG1a (linear
regression (n=37), r
2=0.6065; Fisher’s r to z, p,0.0001) (Figure 2),
using migration data we have previously reported in the same cell
lines.[7] (Three cell lines that were used for the adhesion studies
lacked migration data and so were not included in this comparison.)
These data suggest that the MRVA measure has broader biological
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indicate causation, a varying adhesive state is a biologically plausible
and necessary mechanism for cell migration.
Defining the outcome measures
Given the reliability of the MRVA within a cell line and its
apparent biological significance, the MRVA was established at this
point as the primary dependent measurement for all future
adhesion experiments. In addition, several other dependent
measures were defined and used for studying the effects of
signaling pathway inhibitors. Two other range measures were
defined as follows: 1) ICAM-only MRVA, which is calculated from
the control cells alone (maximum minus minimum of the four time
points) and represents the effects of endogenous signaling and/or
the presence of ICAM itself in modulating varying adhesion over
time, and 2) PMA/vehicle MRVA, which is calculated analo-
gously to NRG/vehicle MRVA and represents the variation in cell
adhesion over time in response to PMA stimulation. A measure of
net baseline attachment also was defined as follows: mean ICAM
effect, which is the average of the four ICAM fluorescence values
and represents the overall ‘‘stickiness’’ or relative adherence state
of the control cells at baseline. In situations where an inhibitor
exerted effects on both baseline and chemical-induced adhesion,
the mean NRG and mean PMA fluorescence values were analyzed
to distinguish effects on the numerator versus the denominator of
the mean NRG/vehicle or mean PMA/vehicle ratios.
NRG1a mediates its effects on cell adhesion through
erbB2 signaling
We previously have demonstrated that NRG1a-mediated migra-
tion of lymphoblasts was dependent on erbB2 signaling; thus, we
tested whether erbB2 stimulation was involved in the mechanism
of NRG1a-induced cell adhesion by treating cells with the selective
erbB2 inhibitor AG825. AG825 exhibited a significant dose-
dependent effect on dampening the MRVA of NRG1a-induced
adhesion (ANOVA, F(3,4)=23.358, p,0.0001) (Figures 3).
Figure 2. The maximum range of NRG1a-induced varying adhesion predicts NRG1a-induced chemotactic migration. Adhesion data were
compared with available data gathered one year previously of NRG1a-induced migration of those same cell lines.
doi:10.1371/journal.pone.0001369.g002
Figure 1. Neuregulin-1 induces temporally varying cell adhesion that appears characteristic of a particular cell line. In response to NRG1a
stimulation over time, cells of a given cell line as a population fluctuate between states of relative detachment and states of relative attachment. In
order to test the reliability of these patterns, ten cell lines on two separate days were tested using our adhesion assay. Two representative examples
are shown. While the timing of peaks and troughs varied between runs, the maximum range of varying adhesion (MRVA) was remarkably consistent
(p=0.016). Calculation of the MRVA for each run of each cell line is shown.
doi:10.1371/journal.pone.0001369.g001
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induced varying cell adhesion
To address the role of PI3K signaling in the NRG1a-induced
adhesion effect, we studied the irreversible PI3K inhibitor
wortmannin. The doses used were all well below concentrations
in which wortmannin cross-reacts with MAPK, myosin light chain
kinase (MLCK), or phosphoinositide-4 kinase signaling in an effort
to specifically target PI3K signaling. Wortmannin exhibited a
significant, dose-dependent, dampening effect on the NRG/
vehicle MRVA (ANOVA, F(3,4)=17.208, p,0.0001) (Figure 4)
with no effects on baseline or PMA-induced adhesion.
Akt inhibition mimics PI3K inhibition and dampens
the NRG1a-induced adhesion effect
The Akt Inhibitor X selectively inhibits the phosphorylation of Akt
with minimal effects on PI3K, PDK1, or SGK1 signaling. The
effects of this drug mirrored the results of PI3K inhibition with a
dose-dependent, significant reduction in NRG/vehicle MRVA
(ANOVA, F(3,4)=4.709, p=0.0214) (Figure 5a) and no effects on
ICAM-alone or PMA/vehicle MRVA. Unlike with PI3K
inhibition, Akt inhibition was associated with a significant
reduction in mean ICAM-alone attachment (ANOVA,
F(3,4)=6.711, p=0.0086) (Figure 5b). However, this reduction
was only seen at the highest dose (p=0.0033). This same effect
also was seen in significantly reducing the raw NRG fluorescence
values at the high dose only (ANOVA, F(3,4)=11.639, p=0.0007)
with no obvious trend at other doses. Given this common effect on
mean ICAM-alone and mean NRG attachment exclusively at the
high dose, it may represent a cross-reaction of the inhibitor at high
concentrations with another signaling pathway important for
maintaining an adhesive state.
Rho kinase is not essential for the NRG1- or PMA-
induced adhesion effects
Since Rho also is downstream of PI3K and has been implicated in
cell adhesion mechanisms,[36,37] it was important to investigate
whether Rho plays a role inNRG1-induced cell adhesion. However,
there are no cell-permeable, specific Rho inhibitors available, so the
Rho-associated protein kinase (ROCK) inhibitor Rho Kinase
Inhibitor IV was used. This ROCK inhibitor had no significant
effects on any of adhesion parameters examined, and so ROCK
signaling does not appear to play any critical role in modulating
baseline, NRG1-induced, or PMA-induced varying adhesion.
MEK signaling is not essential for the NRG1-induced
cell adhesion effect
The selective MEK inhibitor PD98059 had no effect on any of the
adhesion parametersat anydose(not shown).Thissuggeststhateven
were MEK signaling involved inthese processes, itis not essential for
baseline adhesion or NRG1- or PMA-mediated adhesion.
Phospholipase C signaling is necessary for
maintaining an adhesive state in general
Like PI3K, the PLC inhibitor U73122 also caused a significant
reduction in the NRG1a-induced MRVA (ANOVA, F(3,4)=
4.186, p=0.0304) (Figure 6a), but the effect of this inhibitor
Figure 3. The selective erbB2 antagonist AG825 dampens the NRG1a-
induced MRVA. Administration of AG825 in DMSO vehicle (n=5)
caused a robust, dose-dependent decrease in the MRVA induced by
NRG1a. Compared with the vehicle control, ** represents p,0.01 and
**** represents p,0.0001. Compared with the low dose, + represents
p,0.05 and +++ represents p,0.001.
doi:10.1371/journal.pone.0001369.g003
Figure 4. The phosphoinositide-3 kinase (PI3K) inhibitor wortmannin
is essential for variation in NRG1a-induced cell adhesion. Wortman-
nin in DMSO vehicle (n=5) exhibited a strong, dose-dependent,
dampening effect on the NRG/vehicle MRVA measure. Compared with
the vehicle control, * represents p,0.05, ** represents p,0.01, and ****
represents p,0.0001. Compared with the low dose, + represents
p,0.05 and ++ represents p,0.01.
doi:10.1371/journal.pone.0001369.g004
Figure 5. Akt inhibition causes a dampening of the NRG/vehicle MRVA measure. Administration of the Akt Inhibitor X in water vehicle (n=5)
caused a dose-dependent decline in the NRG/vehicle MRVA (A). Unlike PI3K inhibition, Akt inhibition was associated with a statistically significant
reduction in mean ICAM (B) and mean NRG (not shown) raw fluorescence values at the high dose only with no trend at lower doses. Compared with
the vehicle control, * represents p,0.05 and ** represents p,0.01. Compared with the low dose, + represents p,0.05 and ++ represents p,0.01.
doi:10.1371/journal.pone.0001369.g005
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and not an NRG1/erbB2-dependent effect. Both baseline
variability (ICAM-alone MRVA) (ANOVA, F(3,4)=8.883,
p=0.0023) and baseline mean attachment (mean ICAM-alone)
(ANOVA, F(3,4)=4.915, p=0.0186) decreased after exposure to
U73122 (Figures 6b and c, respectively). However, the change in
mean ICAM-alone was only significant at the highest dose
(p=0.0155) (Figure 6c). Likewise, the raw mean NRG and PMA
fluorescence values had significant decreases only at the highest
dose (NRG: ANOVA, F(3,4)=8.672, p=0.0025; PMA: ANOVA,
F(3,4)=4.736, p=0.0210). It is important to note, however, that
neither the mean NRG/vehicle (Figure 6d) nor the mean PMA/
vehicle (Figure 6e) ratios were significantly different across doses,
indicating that PLC inhibition is affecting common cellular
signaling across these pathways to a similar degree independent
of the stimulatory agent. Therefore, although the PLC inhibitor
did exert a significant effect on reducing the NRG/vehicle
MRVA, this likely was due to reducing overall adhesion and
constricting the range of the potential response, rather than to
specific inhibition of an NRG1/erbB2-dependent pathway.
Myosin light chain kinase (MLCK) signaling is
important for baseline adhesion
Given the known importance of MLCK in promoting attachment,
the MLCK inhibitor ML-7 was used to examine its effects on our
various adhesion parameters. As expected, the main effect of
MLCK inhibition was a dose-dependent decrease in mean
ICAM-alone attachment (ANOVA, F(3,4)=17.601, p,0.0001)
(Figure 7a). However, there were no changes in the raw
fluorescence values of PMA (ANOVA, F(3,4)=0.381,
p=0.7686) (Figure 7b) or NRG (ANOVA, F(3,4)=0.322,
p=0.8095) (Figure 7c). No significant effects on any of the three
MRVA parameters were seen. It is also important to highlight that
the effects observed by PLC versus MLCK inhibition were not
identical. PLC inhibition caused decreases in the raw NRG and
PMA fluorescence values, suggesting its broad importance to
multiple common pathways of adhesion. In contrast, MLCK
inhibition seemed to exert an effect restricted to baseline ICAM
adhesion with no effects on the raw mean NRG or PMA
fluorescence values.
NRG1a-induced varying adhesion is dampened in
lymphoblasts derived from patients with
schizophrenia
Given our prior observation that patient-derived lymphoblasts
showed a less robust migratory response to NRG1a and the
current correlation between our migration and adhesion measures,
we predicted that there would also be a MRVA difference between
patients and controls. Indeed, the NRG/vehicle MRVA was
significantly lower in lymphoblasts derived from patients com-
pared with those derived from normal controls (patients (n=20),
0.52060.045; controls (n=20), 0.78060.044; p=0.0002)
(Figure 8a and c). In contrast, the PMA response was similar
between groups, indicating that the patient-derived lymphoblasts
still retained the ability to mediate robust cell adhesion, but were
unable to do so appropriately in response to NRG1a. A series of
Figure 6. Phospholipase C (PLC) is essential for maintaining an adhesive state in general. While the PLC inhibitor U73122 in ethanol vehicle (n=5)
did cause a significant reduction in NRG/vehicle MRVA (A) and a trend towards reduction in PMA/vehicle MRVA (not shown), it exerted a much
stronger effect on dampening baseline MRVA due to the presence of ICAM and endogeneous signaling alone (B). Furthermore, at high dose, it
caused a significant reduction in baseline ICAM attachment (C) and in mean NRG and PMA attachment (raw fluorescence values) (not shown).
However, mean NRG/vehicle (D) and mean PMA/vehicle (E) were not significantly changed. Compared with the vehicle control, * represents p,0.05
and ** represents p,0.01. Compared with the low dose, ++ represents p,0.01 and +++ represents p,0.001.
doi:10.1371/journal.pone.0001369.g006
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possibility that the lack of differences between groups was a dose-
sensitive phenomenon; these tests showed nearly identical wave
forms in all subjects at all assayed concentrations (Figure S2),
further suggesting that the PMA response was normal in the
patient-derived cell lines. It is important to note that PMA also
induced varying levels of adhesion in our assay, similar to but
more extreme than that of NRG1a. Both the MRVA measure of
PMA-induced adhesion (patients (n=20), 1.56160.217; controls
(n=20), 1.35660.121; p=0.4124) (Figure 8b) and the mean
PMA/vehicle (patients (n=20), 2.08360.120; controls (n=20),
1.98060.085; p=0.4840) did not differ between patient-derived
and control-derived cells. There was no difference in mean ICAM
attachment between patient-derived and control-derived cells in
the unstimulated ICAM-alone condition.
COMT genotype predicts the range of variation in
NRG1a-induced adhesion
Given the relationship of single nucleotide polymorphisms in
COMT (val108/158met, rs4680) and in NRG1 (rs6994992) to
NRG1a-induced cell migration established previously,[7] we
sought to determine if NRG1a-induced cell adhesion also showed
such associations. The presence of the schizophrenia risk-
associated COMT val allele showed a strong trend towards
predicting smaller NRG1a-induced MRVA in the entire sample
with similar effects in both groups (unpaired t-test, p=0.0632)
(Figure 9a). ANOVA performed with diagnostic group and
genotype as independent factors revealed no genotype by diagnosis
interactions for either gene. Additionally, there was no effect of
COMT genotype on PMA-induced MRVA (unpaired t-test,
p=0.8727). Because of the low minor allele frequency at NRG1
rs6994992, our study was underpowered to test for an association
with this SNP.
DISCUSSION
We have presented a series of studies that provide evidence that
NRG1a activation of B lymphoblasts induces a temporally varying
cell adhesion response which is mediated by the erbB2/PI3K/
Akt1 pathway and which is abnormal in cells derived from patients
with schizophrenia and affected by COMT val/met genotype. To
our knowledge, these are the first data showing that NRG1a
induces attachment in B lymphoblasts in an assay of cell adhesion,
revealing time-dependent fluctuation in net adhesion. In our
studies, the MRVA of this NRG1a-induced adhesion response has
apparent biological relevance in that it predicts both the degree of
the cell migration response to NRG1a as well as differences
between schizophrenia cases and normal control subjects. In turn,
the MRVA itself may be predicted by a single nucleotide
polymorphism within COMT, which is also implicated in
metastatic cancer. While exogenous NRG1a increases the cell
surface expression of the CD18 integrin (Figure S4), the stable
nature of this effect over time suggests that this increased surface
expression is not directly responsible for mediating the temporally
varying adhesion response. Rather, this NRG1a-induced adhesion
response is dependent on signaling through erbB2, PI3K, and Akt
pathways. PLC and MLCK signaling also play roles in adhesion,
but do not exert NRG1a-specific effects.
Methodological considerations
As the time-dependent variation in cell adhesion in response to
NRG1 is the critical phenomenon upon which the work reported
herein is based, it is important to validate that this variation
represents a real biological effect and is not merely ‘‘noise.’’
Indeed, it could be argued that since our measure is based on a
population of cells that likely is not homogeneous with respect to
attachment states, cell cycle phases, and other biological
phenomena, the MRVA is more likely random than not. We
Figure 7. Myosin light chain kinase (MLCK) is important for baseline attachment. Administration of the MLCK inhibitor ML-7 in DMSO vehicle
(n=5) caused a significant reduction in baseline attachment at the middle and high doses (A). Although this was associated with increases in mean
NRG/vehicle and mean PMA/vehicle (not shown), these effects were merely a consequence of reductions in the denominator as both the raw PMA (B)
and NRG (C) fluorescence values were unchanged. Compared with the vehicle control, ** represents p,0.01 and *** represents p,0.001. Compared
with the low dose, +++ represents p,0.001 and ++++ represents p,0.0001.
doi:10.1371/journal.pone.0001369.g007
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convincingly and consistently that this varying adhesion is not
random: specifically, 1) particular temporal patterns of attachment
and detachment, while not intrinsic to the unstimulated cell itself,
seem to be relatively conserved when cells from the same cell line
under the same conditions at the same time are subjected to
specific stimuli which change their attachment state (Figure S2); 2)
the MRVA is remarkably reliable within a cell line studied on
repeated occasions on different days (Figure 1); 3) the MRVA is
affected in a dose-dependent manner by various relevant signaling
pathway inhibitors (Figures 3–7); 4) the MRVA induced by NRG1
predicts other NRG1-related phenomena in these cells, e.g.
NRG1-induced migration (Figure 2), in contrast to the PMA-
induced MRVA measure, which predicts none of these effects; and
5) the NRG1-induced MRVA is predicted by variation in COMT,
and the pattern of this relationship is similar in patients with
schizophrenia and in normal subjects (Figure 9). We would not
expect to find such systematic properties were the effects simply
noise. On the contrary, we suspect that this varying level of net
adhesion represents, at the individual cell level, an oscillatory
phenomenon related to the cell biology of motility, though we are
unable to confirm mathematically the oscillatory nature of this
phenomenon at this point.
A second potential concern involves the constraints of the time
course experiment itself. In the literature, investigators studying
cell adhesion generally look at one specific time point (often
Figure 9. COMT Val108/158Met predicts variation in cell adhesion. COMT, a putative susceptibility gene for both schizophrenia and metastatic
cancer, previously was shown to have genotype effects on cell migration with the risk genotype rs4680 V/V showing the most impaired migration. In
our adhesion data (n=40), there was a strong trend (p=0.0632) towards decreased NRG1a-induced MRVA of risk homozygotes compared with non-
risk homozygotes (no heterozygote cell lines are maintained).
doi:10.1371/journal.pone.0001369.g009
Figure 8. Neuregulin-1-induced, integrin-mediated varying cell adhesion is impaired in cell lines derived from patients with schizophrenia. The
NRG/vehicle MRVA was significantly lower in lymphoblasts derived from patients compared with those derived from normal controls (A). PMA/
vehicle MRVA was similar between patient-derived and control-derived cell lines (B). The relative impairment in patient-derived cells did not seem to
be isolated to attachment or detachment, but was indicative of an overall more constricted response with less variation from baseline adhesion in
response to NRG1a (C). *** represents p,0.001.
doi:10.1371/journal.pone.0001369.g008
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that NRG1-induced adhesion actually had a time dependency, we
chose four evenly spaced time points over that hour to better
characterize the varying nature of this adhesion. More time points
might be preferable in order to better assess the precise variations
that are occurring. Unfortunately, technical and other consider-
ations make assaying at more frequent time points impractical.
Theoretically, cell adhesion could be fluctuating with a period on
the order of seconds or even more quickly. It is unclear whether
such effects would be observable in a population of cells even with
continuous sampling, which is not possible with our assay. These
considerations notwithstanding, the fact that there are observable
mass effects suggests that the cells have a certain degree of
synchronization in their modulation of adhesion or else no net
effect over time would be expected. This synchronization is not
entirely surprising given that all cells likely are starting at roughly
the same basal adhesive state, due to similar cell and culture
conditions, and then are being exposed to the same exogenous
dose of NRG1a. Cell to cell interactions also likely play a role in
mediating this mass effect. Nevertheless, the MRVA as described
does serve to quantify the range of the adhesion over time in a cell
line and is closely related to NRG1a-induced cell motility. The fact
that our MRVA measure and our measure of NRG1-induced
motility were highly correlated even though the experiments were
performed on average 13 months apart, suggests that these are
biologic characteristics of a cell line and not artifacts of cell
preparation or culture conditions.
Another potential confounder for which it is difficult to control
is the possible effect of endogenous NRG1. It has recently been
shown that B lymphoblasts do not express NRG1,[38] though the
serum in the culture medium likely does contain NRG1. So, even
the cells in the control wells are likely being exposed to low levels
of NRG1, although the relative levels of stimulation are different
from exposure to exogenous NRG1. Pre-exposure to low levels of
serum-derived NRG1 may contribute to baseline ICAM-alone
MRVA. However, assuming that this serum-derived NRG1 effect
is stable over time and independent of exogenous NRG1
stimulation, the fact that we are always comparing NRG1-
stimulated cells to control cells controls for any net effects on
adhesion that serum-derived NRG1 exerts.
The last methodological consideration relates to the form of
NRG1 employed in these studies. While the b form is more potent
and the more widely available form in the central nervous
system,[4] the a form is the type more commonly found in
peripheral tissue. We elected to use the a form based on our
peripherally derived cell type. Studies comparing the relative
effects of the b versus the a form would be of interest.
Integrin-mediated adhesion and cell signaling
The intracellular signaling pathways mediating integrin inside-out
signaling are complex and yet to be fully clarified. Though several
pathways have been implicated in this inside-out signaling, all
seem to operate by one or both of two mechanisms: 1) changing
integrin affinity, at least in part, through phosphorylation of
integrin cytoplasmic domains, which can mediate conformational
changes itself or which may lead to recruitment of other molecules
that help mediate these processes, and 2) altering integrin
clustering,[39] which affects integrin avidity and is dependent on
calcium signaling[40] and the presence of lipid rafts.[41]
Phorbol esters, such as PMA, can promote integrin attachment
by directly activating PKC independent of diacylglycerol.[42]
They appear to do so, at least in part, through PKC
phosphorylation of the b2 integrin and consequent recruitment
of 14-3-3 protein to the activated integrin.[43] However, the
importance of the PKC pathway for integrin activation, especially
in response to chemokine signaling, is unclear since inhibition of
the PKC pathway does not abolish chemokine-induced integrin
activation.[42,44,45] On the other hand, the PI3K pathway
appears to play a fundamental role in modulating cell adhesiveness
through chemokine-induced inside-out signaling pathways.
[46,47,48,49] The PI3K pathway seems to mediate this signaling
via regulation at the integrin cytoplasmic domains.[50] Rho,
which is downstream of PI3K, inhibits clustering of LFA-1
molecules,[37] and the leukocyte-specific RhoH has been
implicated as important in maintaining a nonadhesive state.[36]
However, this picture is complicated by the fact that ROCK
promotes myosin light chain phosphorylation,[51] which leads to
increased attachment. In fact, T lymphocyte migration involves
close regulation of MLCK-mediated attachment and ROCK-
dependent detachment.[52] Additionally, intracellular calcium
fluxes play a role in modulating cell adhesion through a variety of
molecules, including PKC, MLCK, calmodulin,[53] calpain,[40]
calreticulin,[54] and focal adhesion kinase.[55]
Consistent with both the literature[56] and our previous
migration studies, we found that PI3K but not MEK is critical
for mediating NRG1-induced adhesion. Our demonstration of
strong non-specific effects of PLC in maintaining an adhesive state
is consistent with the literature, especially given the known
importance of both PKC and calcium signaling in promoting cell
adhesion. Additionally, the role of MLCK in maintaining an
adhesive state was confirmed by our studies. The lack of effect of
ROCK inhibition on our adhesion studies was unexpected.
However, given ROCK’s particular roles in promoting both
pro-adhesive and anti-adhesive pathways through effects on
MLCK and Rho, respectively, the lack of a robust directional
effect on cell adhesion may be due to complex compensatory
mechanisms in these pathways. Finally, it recently has been
demonstrated that Akt1 plays an important role in integrin
activation through an inside-out pathway, emphasizing a regula-
tory role for Akt1 in cell adhesion and migration.[57] Our data not
only help support these findings but may provide a potential
mechanism towards understanding these regulatory effects.
While we demonstrated differences in our adhesion assay
between our patient-derived and control-derived cells, the
molecular basis of this difference is not yet identified. Our results
could be specific to NRG1-mediated adhesion; they could reflect
diverse sites of molecular pathology in NRG1 signaling related to
the erbB/PI3K/Akt pathway; or the data could be related to more
general phenomena that converge on cell adhesion. At present, the
weight of the evidence suggests that patient-derived lymphoblasts
do not have an intrinsic impairment of either cell attachment or
detachment, but rather seem unable to modulate their adhesive
states from their baseline levels in response to NRG1a.
Potential implications for clinical disease
The strong relationship between the NRG1-induced adhesion
response and the ability of the cells to migrate has potential
implications for several clinical disease entities, most notably
cancer and schizophrenia. Our data may have relevance for
cancer biology, especially for B cell leukemia/lymphoma, multiple
myleloma, and breast and other ErbB2-related cancers. NRG1
also been shown to be sufficient in promoting invasion[58] and
metastasis[59,60] of cancer cells, processes which are dependent
on at least some of the same adhesion mechanisms. Furthermore,
Akt activation has been found to be associated with NRG1-
producing stromal cells and was a negative prognostic marker that
was associated with increased risk of distant metastasis.[61]
Neuregulin1 Regulates Adhesion
PLoS ONE | www.plosone.org 8 December 2007 | Issue 12 | e1369While our studies do not show that the NRG1-induced adhesion
response directly relates to these clinical phenotypes, they provide
a consistent and biologically plausible mechanism that might help
explain them and might be of value in studying them. If NRG1/
erbB signaling in the B lymphoblast proves to be a good model for
understanding aspects of NRG1-mediated neuronal adhesion and
migration, then our findings may also provide insight into better
understanding molecular and genetic mechanisms of schizophre-
nia, in which abnormalities of neuronal migration and synaptic
connectivity have been implicated.[1]
Though we currently have no solid data to explain the
mechanism of the association with COMT, we suggest that it
reflects the impact of a by-product of this methyltransferase
enzyme on cell motility. It has recently been found that s-
adenosylhomocysteine hydrolase (SAHH) is localized at the front
leading edge of migrating cells, suggesting that the endogenous
methyltransferase inhibitor s-adenosylhomocysteine (SAH) needs
to be actively removed at the leading edge[62]. This finding
supports earlier observations that phospholipid methylation occurs
at a rapid turnover rate during cell migration[63] and that
migration is affected substantially by concentrations of s-
adenosylmethionine (SAM) and SAH[64,65]. COMT activity
consumes SAM and generates SAH. COMT val alleles have about
twice the enzyme activity of met alleles[66], predicting that they
would generate relatively more SAH. Thus, it is possible that the
COMT val/met polymorphism affects phospholipid methylation
by modifying the SAM/SAH ratio, with val alleles thus having a
lower ratio and poorer adhesion/migration.
It is also interesting to note that COMT is implicated in cancer
biology and metastasis, and the allelic directionality is consistent
with our results (i.e. here met alleles are risk-associated)[67].
Finally, our adhesion studies and findings have brought at least
three promising schizophrenia susceptibility genes–NRG1,
COMT, and Akt1–together in a coherent, biologically plausible
framework. Not only does this underscore the polygenic
complexity of cell adhesion and migration, but it provides a
possible mechanism for the risk towards schizophrenia that these
particular susceptibility genes confer.
MATERIALS AND METHODS
Subjects
Blood collection and transformation of lymphocytes were
approved by the NIMH institutional review board, and all donors
gave written, informed consent. The B lymphoblast cell lines were
gathered separately in two cohorts. The first cohort was derived
from 15 normal controls (8 females, 7 males; age 34.962.4 years
at the time of blood collection) and 13 individuals with
schizophrenia (6 females, 7 males; age 36.363.6 years). A second
cohort of B lymphoblasts was derived from 20 normal controls (10
females, 10 males; age 29.762.2 years) and 11 individuals with
schizophrenia (5 females, 6 males; age 38.763.5 years). All
subjects were drawn from individuals participating in the Clinical
Brain Disorders Branch ‘‘Sibling Study’’ protocol, an ongoing
investigation of neurobiological abnormalities related to genetic
risk for schizophrenia. The details of subject recruitment and
examination are described elsewhere.[68] Only Caucasian sub-
jects of self-reported European ancestry were included to avoid
genetic stratification and to reduce heterogeneity. Because of our
prior interest in studying the effects of the COMT val108/158met
polymorphism on various phenotypes, B lymphoblasts were
selected only from val or met homozygous individuals for both
case and control groups to increase statistical power for
comparison. While every available cell line (n=59) was assayed
for baseline integrin expression, a total of 40 cell lines was tested
using our adhesion assay to provide an equal number in the
following categories: 1) schizophrenia, COMT val/val genotype;
2) schizophrenia, COMT met/met; 3) normal control, COMT
val/val; 4) normal control, COMT met/met. These cell lines are
derived from the same individuals described in our report on cell
migration,[7] but represent cultures of transformed cells grown
months apart from different frozen pellets of the original stock. For
the cell lines used for these studies, patients and controls did not
differ significantly in age (p=0.5331 for total sample), gender, or
race in either of the cohorts or in the total sample. For the
pharmacological assays, each inhibitor was tested on five control
cell lines, and the cell lines used for these assays varied based only
on the availability of cells at the time of testing.
B lymphoblast culture
Mononuclear cells were isolated by Ficoll-Hypaque density
gradient centrifugation. B lymphocytes in the mononuclear cell
preparation were transformed by infection with EBV as previously
described.[69] The transformed B lymphoblasts were grown in
RPMI-1640 medium (Gibco, Grand Island, NY) containing L-
glutamine (2 mmol/L) (Gibco), 10% fetal bovine serum (FBS)
(Cambrex, Walkersville, MD), 100 mg/mL streptomycin, and
100 units/mL penicillin (Gibco) in an incubator (95% air/5%
CO2 at 37uC). The same lot of medium was used for all
experiments. Cell lines periodically are recovered from the original
stock every 3 months.
Flow cytometric analyses of integrin expression
For the baseline integrin expression experiments, 0.5 million cells
were stained with either FITC anti-human CD11a (BD Pharmin-
gen, San Diego, CA) or FITC anti-human CD18 (BD Pharmin-
gen). The same number of cells also was stained with FITC anti-
mouse IgG1 (BD Pharmingen) for use as a negative control. For
each integrin and cell line, the median fluorescence values were
taken from gated regions of 10 000 live cells using a FACScan
(Becton Dickinson, Franklin Lakes, NJ). A corrected median
fluorescence was calculated by subtracting the negative control
median fluorescence from the integrin median fluorescence. For
the experiments looking at integrin expression following stimula-
tion with recombinant human NRG1a (R&D Systems, Inc,
Minneapolis, MN), 0.5 million cells were stained with either
FITC anti-human CD11a or PE anti-human CD18 (BD
Pharmingen). Unstimulated cells from the same cell lines were
used as controls.
Cell adhesion assay
Recombinant human ICAM-1 (ICAM) (R&D Systems) was
adsorbed at 10 mg/ml (1 mg/well) to black, non-treated, 96-well
plates (Nalge Nunc International, Rochester, NY) overnight at
4uC. Nonspecific adhesion was blocked with 3% bovine serum
albumin (BSA) (Sigma-Aldrich, Allentown, PA) in phosphate
buffered saline (PBS) for 2 hours at 4uC. Plates were washed 3
times each with PBS to remove nonadsorbed ICAM and BSA. 50
000 cells/well were added in triplicate to the plates, which were
preloaded with control buffer (Hanks’ Buffered Salt Solution
(HBSS) with calcium and 10 mM HEPES), 50 ng/ml recombi-
nant human NRG1a (R&D Systems) in control buffer, or 150 nM
phorbol myristate acetate (PMA) (Sigma-Aldrich) in control buffer.
The cells were allowed to incubate at 37uC for 15, 30, 45, or
60 minutes. At each of these time intervals, the plates were washed
gently 4 times each with HBSS containing calcium using a 12-tip
multi-pipettor. 150 ml PBS and 50 ml CyQuant GR dye/lysis
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were added to each well. Plates were incubated in the dark on an
orbital shaker at 100 rpm for 15 minutes and then read 5 times
each using a Victor3 1420 Multilabel Counter fluorescence
microplate reader (Perkin Elmer, Wellesley, MA). The read-out,
therefore, was fluorescence-based quantification of the DNA of the
cells that remained attached, and thus served as a proxy to
quantify the number of adherent cells. We also performed a series
of studies in two cell lines with five minute sampling rates (Figure
S3). While this approach allowed a more complete characteriza-
tion of the range of varying adhesion, it revealed no evidence of a
regular pattern over this time period. Thus, we concluded that
sampling noise would not be systematically affected by the
15 minute frequency, which was much less labor intensive and
more practical for the full sample.
In a given experiment for the non-pharmacological inhibitor
studies, four cell lines were assayed as a batch. A different plate was
used for each time point. The placement of cell lines on each plate
was varied such that cell lines derived from patients with
schizophrenia versus normal controls were in different positions in
different experiments, but in any given individual experiment, both
patient-derived and control-derived cell lines were used. While the
investigator was not blinded as to the plate arrangement, the
washings were done with a 12-tip multi-pipettor such that wells
containing different cell lines derived from individuals with and
without the diagnosisof schizophrenia were washed at the sametime
and with the same technique. For the pharmacological assays, one
cell line was assayed per experiment. For these studies, the plates
were arranged such that the unstimulated wells from all treatment
groupswerewashedatthesametimeandwiththesametechniqueas
were the NRG1 wells and the PMA wells.
The effectof NRG1astimulationwasmeasuredateachtimepoint
based oncalculation ofa ratio (NRG/vehicle) (Figure S1), whichwas
determined by taking the mean of the triplicate NRG1a-stimulated
fluorescence values and dividing by the mean of the triplicate of the
control ICAM-alone fluorescence values. This normalization
procedure was adopted because raw baseline adhesion states tended
to show some drift over time, albeit much less than the pronounced
variation in adhesion after NRG1 stimulation (Figure S1). Thus, the
use of this ratio helps to control for other cellular and environmental
processes that may impact adhesion. An analogous procedure was
done to determine the effect of PMA stimulation, based on a PMA/
vehicle ratio at each time point.
Dose response curves for NRG1a and PMA were performed
across five NRG1a doses from 1–200 ng/ml and across five PMA
doses from 1.5–300 nM (not shown). NRG1a had a slight peak in
the MRVA around 50 ng/ml, so all cell lines were subjected to
this concentration for all experiments. The PMA response was
similar at commonly used dosages in the literature (100–300 nM)
as well as at doses 100 times below those concentrations, so
150 nM was arbitrarily selected for the positive control as it was a
modest dose relative to the literature.
For signaling pathway inhibitor pharmacological assays, cells
were incubated with the particular inhibitor in the dark at room
temperature for 40–60 minutes prior to plating. The inhibitors
(AG825, wortmannin, Akt inhibitor X, Rho kinase inhibitor IV,
PD98059, U73122, and ML-7) were obtained from Calbiochem,
San Diego, CA. Unstimulated control cells for these experiments
were incubated with equal volume of vehicle containing the
particular inhibitor. Concentrations for inhibition were chosen by
the middle concentration being approximately at the average IC50
reported in the literature (references per manufacturer’s catalog).
High and low doses were 10 times greater and 10 times less,
respectively, than the middle dose.
Statistical Analyses
Between groups comparisons were performed by unpaired t-tests or
factorial ANOVA, where applicable. Effects of NRG1a on integrin
expression and effects of signaling inhibitors both were analyzed by
one-way repeated measure ANOVA to compare the dependent
measures of the treated versus untreated cells. The effect of COMT
genotype on the NRG/vehicle MRVA was assessed by one-tailed
group comparison. All ANOVAs were followed by Fisher’s post-hoc
comparison matrices. Unless otherwise stated, data were expressed
as mean +/2 standard error of the mean (SEM).
SUPPORTING INFORMATION
Figure S1 Variation of attachment induced by NRG1 and
PMA. The NRG/ICAM and PMA/ICAM values were designed
to isolate the effects of NRG1a or PMA on the cell adhesion state
and thereby control for the vast array of other cellular and
environmental processes that can impact adhesion. These data
illustrate that the use of such ratios is a justified transformation of
the data and that the variable adhesion states are not an artifact
simply of changing ICAM-alone baseline adhesion. Displayed are
raw fluorescence values of ICAM-alone, NRG, and PMA data
from three experiments on different days using different cell lines.
(A, C, E). These data show that although baseline adhesion shows
little variation over time, NRG and PMA adhesion do consider-
ably. The NRG/vehicle and PMA/vehicle ratios for those same
three experiments also are shown next to their respective raw data
(B, D, F).
Found at: doi:10.1371/journal.pone.0001369.s001 (0.85 MB TIF)
Figure S2 Varying adhesion patterns show individual consis-
tency. Cells from three cell lines were subjected in the same
experiment at the same time to three doses of PMA over two
orders of magnitude (A-C). Wells from the three different cell lines
were washed together at the same time and with the same
technique using a 12-tip multi-pipettor. Within a cell line, the
same general pattern of varying cell adhesion over time was
conserved. However, the patterns of varying cell adhesion were
quite different between cell lines with peaks and troughs occurring
at different time points despite undergoing washings together at
the exact same time with the multi-pipettor. This suggests that the
response of cells from a particular cell line under the same
conditions is relatively synchronized and that the varying adhesion
observed is less likely to be simply noise.
Found at: doi:10.1371/journal.pone.0001369.s002 (0.34 MB TIF)
Figure S3 The MRVA appears intrinsic to a particular cell line
and is dampened upon inhibition of involved signaling pathways.
A representative example of one control cell line assayed at
5 minute time points with and and without PI3K inhibition by
wortmannin. While there is no predictable pattern, the vehicle
cells continue to recapitulate the same approximate peak and
trough multiple times over the time course. The MRVA for the
wortmannin-treated cells is substantially lower than the MRVA for
cells treated only with DMSO vehicle (wortmannin MRVA: 0.779,
vehicle MRVA: 1.211). As the cells can fluctuate over a 5 minute
period from states of relatively strong net attachment to states of
relatively strong net detachment, there is no obvious advantage to
using 5 minute time points instead of 15 minute time points in
order to help characterize the range of variability. All wells for
each time point were washed at the same time and with the same
technique using a 12-tip multi-pipettor.
Found at: doi:10.1371/journal.pone.0001369.s003 (0.33 MB TIF)
Figure S4 CD18, but not CD11a, integrin surface expression
increases with NRG1a stimulation. Cells from 5 cell lines derived
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controls were stimulated with NRG1a for 0, 15, 30, 45, or
60 minutes and then stained with anti-CD11a (aL) FITC-
conjugated (A) or anti-CD18 (b2) PE-conjugated (B) antibodies
and analyzed for expression by FACScan. The median fluores-
cence of 10 000 gated live cells was calculated for each cell line.
Group data for both figures reflect the means of individual cell
lines’ median fluorescence values. *** represents p,0.001 and is
the post-hoc value for every 2-way comparison with t=0.
Found at: doi:10.1371/journal.pone.0001369.s004 (0.10 MB TIF)
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